DENVER, Aug. 27, 2014 /PRNewswire/ -- MSC, a healthcare performance improvement company advancing clinical quality and patient safety, today announced the appointment of Mary Beth Loesch to President and CEO.
With 28 years of experience preparing companies for rapid growth and market expansion, Loesch joined MSC in 2013 as Executive Vice President of Corporate Development and Healthcare. In that role, she oversaw MSC's healthcare performance improvement business, as well as corporate strategy and marketing. Previously, Loesch served as Senior Vice President of Business Development and Marketing for StarTek, a publicly-traded global business processing outsourcing firm. Loesch has provided senior executive leadership to a variety of private equity backed firms and brings a vast range of specialties to MSC, including executing corporate strategy, business development, international expansion, merger and acquisition, as well as marketing and operations.
Loesch succeeds Bill Younkes after 14 years at the helm of MSC. "We could not find a more capable executive to lead MSC in its next phase of growth," says Younkes. "Mary Beth's experience and talent in leading innovative and rapidly-growing organizations will support MSC's mission to advance clinical quality and patient safety in hospitals across the U.S."
MSC is a healthcare performance improvement company, advancing clinical quality and patient safety to help solve hospitals' most costly and complex problems, like sepsis. MSC's Sepsis Quality Solution integrates immersive technology, clinical expertise, analytics and practice improvement to advance hospital sepsis performance for reduced mortality, reduced acuity, and reduced healthcare cost. MSC's Simulation Solutions have earned the exclusive endorsement of the American Hospital Association. For more information, visit www.medsimulation.com or call 888/889-5882.